Announcements

1. “L-Carnitine and Acylcarnitines: Mitochondrial Biomarkers for Precision Medicine”
*Editor’s Choice Paper
by Marc R. McCann, Mery Vet George De la Rosa, Gus R. Rosania and Kathleen A. Stringer
Metabolites 2021, 11(1), 51; https://doi.org/10.3390/metabo11010051
Available online: https://www.mdpi.com/2218-1989/11/1/51

2. “The Effects of Plant-Associated Bacterial Exopolysaccharides on Plant Abiotic Stress Tolerance”
by Rafael J. L. Morcillo and Maximino Manzanera
Metabolites 2021, 11(6), 337; https://doi.org/10.3390/metabo11060337
Available online: https://www.mdpi.com/2218-1989/11/6/337

3. “Metabolic Reprogramming of Cancer Cells during Tumor Progression and Metastasis”
by Kenji Ohshima and Eiichi Morii
Metabolites 2021, 11(1), 28; https://doi.org/10.3390/metabo11010028
Available online: https://www.mdpi.com/2218-1989/11/1/28

4. “The Effects of SGLT2 Inhibitors on Lipid Metabolism”
by Zsolt Szekeres, Kalman Toth and Eszter Szabados
Metabolites 2021, 11(2), 87; https://doi.org/10.3390/metabo11020087
Available online: https://www.mdpi.com/2218-1989/11/2/87

5. “Vitamin D Sources, Metabolism, and Deficiency: Available Compounds and Guidelines for Its Treatment”
*Editor’s Choice Paper
by Ligia J. Dominguez, Mario Farruggia, Nicola Veronese and Mario Barbagallo
Metabolites 2021, 11(4), 255; https://doi.org/10.3390/metabo11040255
Available online: https://www.mdpi.com/2218-1989/11/4/255

6. “Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target”
by Jennifer Behbodikhah, Saba Ahmed, Ailin Elyasi, Lora J. Kasselman, Joshua De Leon, Amy D. Glass and Allison B. Reiss
Metabolites 2021, 11(10), 690; https://doi.org/10.3390/metabo11100690
Available online: https://www.mdpi.com/2218-1989/11/10/690

7. “Linking Gut Microbiome and Lipid Metabolism: Moving beyond Associations”
*Feature Paper
by Santosh Lamichhane, Partho Sen, Marina Amaral Alves, Henrique C. Ribeiro, Peppi Raunioniemi, Tuulia Hyötyläinen and Matej Orešič
Metabolites 2021, 11(1), 55; https://doi.org/10.3390/metabo11010055
Available online: https://www.mdpi.com/2218-1989/11/1/55

8. “Glutathione Metabolism in Plants under Stress: Beyond Reactive Oxygen Species Detoxification”
by Sonia Dorion, Jasmine C. Ouellet and Jean Rivoal
Metabolites 2021, 11(9), 641; https://doi.org/10.3390/metabo11090641
Available online: https://www.mdpi.com/2218-1989/11/9/641

9. “The Chemistry of Stress: Understanding the ‘Cry for Help’ of Plant Roots”
by Muhammad Syamsu Rizaludin, Nejc Stopnisek, Jos M. Raaijmakers and Paolina Garbeva
Metabolites 2021, 11(6), 357; https://doi.org/10.3390/metabo11060357
Available online: https://www.mdpi.com/2218-1989/11/6/357

10. “Sensing and Signaling of Methionine Metabolism”
by Linda Lauinger and Peter Kaiser
Metabolites 2021, 11(2), 83; https://doi.org/10.3390/metabo11020083
Available online: https://www.mdpi.com/2218-1989/11/2/83

The 2022 citation metrics have been released in the Journal Citation Reports (JCR), and we’re pleased to announce the following results for MDPI journals:

We are thrilled to announce that 90% of our ranked MDPI journals, specifically 86 out of 96 (captured in the table below), are performing above average in Q1 or Q2. This year, Clarivate has expanded its Impact Factor (IF) awards to include journals in the Emerging Sources Citation Index (ESCI) and the Arts and Humanities Citation Index (AHCI), providing greater transparency for the full set of journals indexed in the Web of Science Core Collection. As a result, 111 of MDPI journals have received their first IF in 2023, with 37 journals surpassing an IF of 3.0. In total, 208 MDPI journals have been honored with an IF.

Clarivate explains that by "expanding the coverage but holding to highly selective standards, the [Impact Factor] is now a reliable indicator of trustworthiness, as well as a measure of scholarly impact, at the journal level."

Please visit our blog post where we discuss the release of the latest citation metrics with our Indexing Manager, Dr. Constanze Schelhorn, to find out what's different this time around and how to make use of different metrics available.

Note: The Journal of Personalized Medicine's Impact Factor was omitted in the original release and will be assigned separately. Please find the data on the journal webpage in due course.

Source: 2022 Journal Impact Factors, Journal Citation Reports ^TM (Clarivate, 2023)

The articles below have been selected as 2022 Issue Cover Articles by the Editorial Office of Metabolites (ISSN: 2218-1989). These articles are from multiple fields within the scope of Metabolites, and we hope they can provide insights and references for scholars in related fields.

The articles below have been selected as 2021 Issue Cover Articles by the Editorial Office of Metabolites (ISSN: 2218-1989). These articles are from multiple fields within the scope of Metabolites, and we hope they can provide insights and references for scholars in related fields.

Conference: 19^th Annual International Conference of the Metabolomics Society

Date: 18–22 June 2023

Place: Niagara Falls Convention Centre, 6815 Stanley Avenue, Niagara Falls, Ontario, Canada L2G 3Y9

Booth: #T12

MDPI will be attending the 19^th Annual International Conference of the Metabolomics Society, which will be held from 18 to 22 June 2023 in downtown Niagara Falls, Canada, at the Niagara Falls Convention Centre.

The conference is the official annual meeting of the Metabolomics Society, and the largest metabolomics meeting worldwide. It will cover the major scientific themes of: technology advances; computational metabolomics, statistics, and bioinformatics; metabolomics in health and disease; and metabolomics of plants, food, environment and microbes. A special theme for this conference will focus on mental health, drug addiction and medicinal cannabis. The scientific program will include plenary and keynote talks, three parallel scientific sessions, interactive poster sessions, sponsor lunches, other networking events and a specially organized parallel session to promote metabolomics research in industry. A strong line-up of both introductory and advanced workshops will take place on Sunday, 18 June, and the morning of Monday, 19 June. To complement the exciting scientific program, the conference will offer a welcome reception, vibrant early career events, a conference dinner and other engaging social activities.

The following MDPI journals will be represented:

• Metabolites;
• Agronomy;
• Antioxidants;
• Applied Biosciences;
• BioMed;
• BioMedInformatics;
• Biomolecules;
• Cancers;
• Cells;
• Children;
• CIMB;
• Diseases;
• Foods;
• Genes;
• JPM;
• Nutrients;
• Plants.

Please do not hesitate to reach out (metabolites@mdpi.com) if you plan on attending this conference. Our delegates look forward to meeting you in person and answering any questions that you might have.

For more information about the conference, please visit the following website: https://www.metabolomics2023.org/.

Conference: ATS (American Thoracic Society) Conference 2023
Date: 21–23 May 2023
Location: Washington DC, USA

MDPI will be attending ATS 2023 as an exhibitor; we welcome researchers from different backgrounds to visit and share their latest ideas with us.

This conference has been organized by the American Thoracic Society, and it will showcase the latest advances and discoveries in respiratory science, patient care and global respiratory health. At the conference, specialists will share and discuss the latest research and its applications to clinical, basic, and translational science in pulmonary, critical care, and sleep medicine.

The following MDPI journals will be represented:

• JCM;
• Medicina;
• Clinics and Practice;
• JPM;
• Cancers;
• Medicines;
• Healthcare;
• Metabolites;
• Children;
• Brain Sciences.

If you are planning to attend this conference, please do not hesitate to talk with us online. Our delegates look forward to meeting you in person at booth #2606, and answering any questions that you may have. For more information about the conference, please visit the following website: https://conference.thoracic.org/.

1. “Metabolomics and the Multi-Omics View of Cancer”
by David Wishart
Metabolites 2022, 12(2), 154; https://doi.org/10.3390/metabo12020154
Available online: https://www.mdpi.com/2218-1989/12/2/154

2. “Signatures of Mitochondrial Dysfunction and Impaired Fatty Acid Metabolism in Plasma of Patients with Post-Acute Sequelae of COVID-19 (PASC)”
by Vamsi P. Guntur, Travis Nemkov, Esther de Boer, Michael P. Mohning, David Baraghoshi, Francesca I. Cendali, Inigo San-Millán, Irina Petrache and Angelo D’Alessandro
Metabolites 2022, 12(11), 1026; https://doi.org/10.3390/metabo12111026
Available online: https://www.mdpi.com/2218-1989/12/11/1026

3. “Evaluation of Syrosingopine, an MCT Inhibitor, as Potential Modulator of Tumor Metabolism and Extracellular Acidification”
by Chloe Buyse, Nicolas Joudiou, Aude Warscotte, Elena Richiardone, Lionel Mignion, Cyril Corbet and Bernard Gallez
Metabolites 2022, 12(6), 557; https://doi.org/10.3390/metabo12060557
Available online: https://www.mdpi.com/2218-1989/12/6/557

4. “Vertical Transfer of Metabolites Detectable from Newborn’s Dried Blood Spot Samples Using UPLC-MS: A Chemometric Study”
by Alessandra Olarini, Madeleine Ernst, Gözde Gürdeniz, Min Kim, Nicklas Brustad, Klaus Bønnelykke, Arieh Cohen, David Hougaard, Jessica Lasky-Su, Hans Bisgaard et al.
Metabolites 2022, 12(2), 94; https://doi.org/10.3390/metabo12020094
Available online: https://www.mdpi.com/2218-1989/12/2/94

5. “Optimisation of the HS-SPME/GC-MS Approach by Design of Experiments Combined with Chemometrics for the Classification of Cretan Virgin Olive Oils”
by Artemis Lioupi, Ioannis Sampsonidis, Christina Virgiliou, Vassiliki T. Papoti, Kyriaki G. Zinoviadou, Apostolos Spyros and Georgios Theodoridis
Metabolites 2022, 12(2), 114; https://doi.org/10.3390/metabo12020114
Available online: https://www.mdpi.com/2218-1989/12/2/114

6. “Optimization of LC-MS² Data Acquisition Parameters for Molecular Networking Applied to Marine Natural Products”
by Sam Afoullouss, Agata Balsam, A. Louise Allcock and Olivier P. Thomas
Metabolites 2022, 12(3), 245; https://doi.org/10.3390/metabo12030245
Available online: https://www.mdpi.com/2218-1989/12/3/245

7. “Camu-Camu Reduces Obesity and Improves Diabetic Profiles of Obese and Diabetic Mice: A Dose-Ranging Study”
by Anne Abot, Amandine Brochot, Nicolas Pomié, Eve Wemelle, Céline Druart, Marion Régnier, Nathalie M. Delzenne, Willem M. de Vos, Claude Knauf and Patrice D. Cani
Metabolites 2022, 12(4), 301; https://doi.org/10.3390/metabo12040301
Available online: https://www.mdpi.com/2218-1989/12/4/301

8. “Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease”
by Émilie Gobeil, Ina Maltais-Payette, Nele Taba, Francis Brière, Nooshin Ghodsian, Erik Abner, Jérôme Bourgault, Eloi Gagnon, Hasanga D. Manikpurage, Christian Couture et al.
Metabolites 2022, 12(5), 440; https://doi.org/10.3390/metabo12050440
Available online: https://www.mdpi.com/2218-1989/12/5/440

1. “Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease”
by Peipei Li, Bryan A. Killinger, Elizabeth Ensink, Ian Beddows, Ali Yilmaz, Noah Lubben, Jared Lamp, Meghan Schilthuis, Irving E. Vega, Randy Woltjer et al.
Metabolites 2021, 11(1), 29; https://doi.org/10.3390/metabo11010029
Available online: https://www.mdpi.com/2218-1989/11/1/29

2. “Metabolomics and Lipidomics: Expanding the Molecular Landscape of Exercise Biology”
*Editor’s Choice Paper
by Mehdi R. Belhaj, Nathan G. Lawler and Nolan J. Hoffman
Metabolites 2021, 11(3), 151; https://doi.org/10.3390/metabo11030151
Available online: https://www.mdpi.com/2218-1989/11/3/151

3. “Salivary Metabolomics for Diagnosis and Monitoring Diseases: Challenges and Possibilities”
by Eelis Hyvärinen, Minttu Savolainen, Jopi J. W. Mikkonen and Arja M. Kullaa
Metabolites 2021, 11(9), 587; https://doi.org/10.3390/metabo11090587
Available online: https://www.mdpi.com/2218-1989/11/9/587

4. “Optical Microscopy-Guided Laser Ablation Electrospray Ionization Ion Mobility Mass Spectrometry: Ambient Single Cell Metabolomics with Increased Confidence in Molecular Identification”
*Editor’s Choice Paper
by Michael J. Taylor, Sara Mattson, Andrey Liyu, Sylwia A. Stopka, Yehia M. Ibrahim, Akos Vertes and Christopher R. Anderton
Metabolites 2021, 11(4), 200; https://doi.org/10.3390/metabo11040200
Available online: https://www.mdpi.com/2218-1989/11/4/200

5. “Metabolomics Diagnosis of COVID-19 from Exhaled Breath Condensate”
by Elettra Barberis, Elia Amede, Shahzaib Khoso, Luigi Castello, Pier Paolo Sainaghi, Mattia Bellan, Piero Emilio Balbo, Giuseppe Patti, Diego Brustia, Mara Giordano et al.
Metabolites 2021, 11(12), 847; https://doi.org/10.3390/metabo11120847
Available online: https://www.mdpi.com/2218-1989/11/12/847

6. “Plasma Metabolome and Lipidome Associations with Type 2 Diabetes and Diabetic Nephropathy”
by Yan Ming Tan, Yan Gao, Guoshou Teo, Hiromi W. L. Koh, E Shyong Tai, Chin Meng Khoo, Kwok Pui Choi, Lei Zhou and Hyungwon Choi
Metabolites 2021, 11(4), 228; https://doi.org/10.3390/metabo11040228
Available online: https://www.mdpi.com/2218-1989/11/4/228

7. “Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review”
by Cristina Piras, Antonio Noto, Luciano Ibba, Martino Deidda, Vassilios Fanos, Sandro Muntoni, Vera Piera Leoni and Luigi Atzori
Metabolites 2021, 11(10), 694; https://doi.org/10.3390/metabo11100694
Available online: https://www.mdpi.com/2218-1989/11/10/694

8. “Metabolomics Studies in Psoriatic Disease: A Review”
by John Koussiouris, Nikita Looby, Melanie Anderson, Vathany Kulasingam and Vinod Chandran
Metabolites 2021, 11(6), 375; https://doi.org/10.3390/metabo11060375
Available online: https://www.mdpi.com/2218-1989/11/6/375

1. “Salivary Metabolomics for Oral Squamous Cell Carcinoma Diagnosis: A Systematic Review”
by Kacper Nijakowski, Dawid Gruszczyński, Dariusz Kopała and Anna Surdacka
Metabolites 2022, 12(4), 294; https://doi.org/10.3390/metabo12040294
Available online: https://www.mdpi.com/2218-1989/12/4/294

2. “Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies”
by Irene Caruso, Angelo Cignarelli, Gian Pio Sorice, Annalisa Natalicchio, Sebastio Perrini, Luigi Laviola and Francesco Giorgino
Metabolites 2022, 12(2), 183; https://doi.org/10.3390/metabo12020183
Available online: https://www.mdpi.com/2218-1989/12/2/183

3. “The Role of Nutraceutical Containing Polyphenols in Diabetes Prevention”
by Iva Fernandes, Joana Oliveira, Aryane Pinho and Eugenia Carvalho
Metabolites 2022, 12(2), 184; https://doi.org/10.3390/metabo12020184
Available online: https://www.mdpi.com/2218-1989/12/2/184

4. “Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH”
by Ryan D. Welch, Cyrielle Billon, McKenna Losby, Gonzalo Bedia-Diaz, Yuanying Fang, Amer Avdagic, Bahaa Elgendy, Thomas P. Burris and Kristine Griffett
Metabolites 2022, 12(3), 238; https://doi.org/10.3390/metabo12030238
Available online: https://www.mdpi.com/2218-1989/12/3/238

5. “Extracellular Matrix in Heart Disease: Focus on Circulating Collagen Type I and III Derived Peptides as Biomarkers of Myocardial Fibrosis and Their Potential in the Prognosis of Heart Failure: A Concise Review”
by Asparuh Nikolov and Nikola Popovski
Metabolites 2022, 12(4), 297; https://doi.org/10.3390/metabo12040297
Available online: https://www.mdpi.com/2218-1989/12/4/297

6. “Fetuin-A in Activated Liver Macrophages Is a Key Feature of Non-Alcoholic Steatohepatitis”
by Quentin Etienne, Valérie Lebrun, Mina Komuta, Benoît Navez, Jean-Paul Thissen, Isabelle A. Leclercq and Nicolas Lanthier
Metabolites 2022, 12(7), 625; https://doi.org/10.3390/metabo12070625
Available online: https://www.mdpi.com/2218-1989/12/7/625

7. “Assessment of Fruit and Vegetables Intake with Biomarkers in Children and Adolescents and Their Level of Validation: A Systematic Review”
by Li Yuan, Samuel Muli, Inge Huybrechts, Ute Nöthlings, Wolfgang Ahrens, Augustin Scalbert and Anna Floegel
Metabolites 2022, 12(2), 126; https://doi.org/10.3390/metabo12020126
Available online: https://www.mdpi.com/2218-1989/12/2/126

8. “The Intestinal Barrier—Shielding the Body from Nano- and Microparticles in Our Diet”
by Marlene Schwarzfischer and Gerhard Rogler
Metabolites 2022, 12(3), 223; https://doi.org/10.3390/metabo12030223
Available online: https://www.mdpi.com/2218-1989/12/3/223